Status:
UNKNOWN
Compliance of Blood Pressure and Lipid in Hypertensive Patients Under the Management of Hospitals at Different Levels
Lead Sponsor:
China Cardiovascular Association
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This is a multi-center, prospective cohort study that collects only diagnostic and therapeutic data in subjects but does not interfere with treatment.
Detailed Description
The study aims to assess blood pressure and lipid levels, the use of lipid-lowering and antihypertensive drugs, and treatment compliance and adverse events in hypertensive outpatients of 30 hospitals ...
Eligibility Criteria
Inclusion
- Patients meeting the following criteria will be included:
- Age ≥18 years, male or female;
- Agreement for blood pressure and lipid testing;
- Initial diagnosis of primary hypertension, with blood pressure conforming to the diagnostic criteria of the 2018 Guidelines for the Prevention and Treatment of Hypertension in China \[14\] (with no antihypertensive drugs, SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg after three tests performed on different days); or a history of primary hypertension but incompliant blood pressure;
- Willingness to participate in the study and signing of informed consent.
Exclusion
- Patients meeting the following criteria will be excluded:
- Involvement in an interventional clinical research;
- Pregnancy or lactation in women;
- Complication with malignant tumors;
- Diagnosis of non-primary hypertension by researchers;
- Impaired cognitive ability;
- Researchers believing that the patients have other conditions not suitable for the study.
Key Trial Info
Start Date :
August 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2020
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT04015843
Start Date
August 22 2019
End Date
November 30 2020
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan Asia Heart Hospital
Wuhan, Hubei, China